Hungarian Translation and Validation of the Pelvic Organ Prolapse Symptom Score
International Urogynecology Journal · 2025
DOI: 10.1007/s00192-025-06090-5 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Szilard Kolumban und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Pecs School of Medicine, Pecs, Hungary. Hauptthemen laut MEDLINE: Pelvic Organ Prolapse, Symptom Assessment. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pécs.
Abstract (Originalsprache)
Introduction and Hypothesis Pelvic organ prolapse (POP) significantly affects women’s quality of life, making the availability of validated, culturally adapted tools for reliable symptom evaluation essential. In this study, the Pelvic Organ Prolapse Symptom Score (POP-SS) was translated into Hungarian and validated, with the assessment of its psychometric properties for clinical and research use.
Methods
In total, 125 women diagnosed with symptomatic POP (Pelvic Organ Prolapse Quantification Score—POP-Q stage ≥ 2) completed the Hungarian POP-SS (POP-SS-H), the Hungarian version of the Australian Pelvic Floor Questionnaire (AFPQ-H), and the short version of the World Health Organization Quality of Life questionnaire (WHOQOL-BREF). Exploratory factor analysis was performed, McDonald’s ω was used to assess internal consistency, and intraclass correlation coefficients (ICCs) were used to examine test–retest reliability over a 2-week interval.
Results
The POP-SS-H demonstrated strong psychometric properties (overall ICC = 0.96, p < 0.001). Item ICCs were 0.69–0.99, with “difficulty in emptying the bladder” being the most stable. The scale has a two-factor ("prolapse and urinary distress" and "abdominal strain and bowel discomfort”) structure. McDonald’s ω was 0.75, confirming its good internal consistency. The scale’s convergent validity was demonstrated through correlations with AFPQ-H and WHOQOL-BREF subscale scores.
Conclusions
The POP-SS-H is a reliable and valid instrument for the assessment of prolapse-related symptoms. Its high degrees of test–retest reliability and internal consistency make it suitable for clinical follow-up and research. The tool addresses a significant gap in pelvic-floor disorder management in Hungary, although further research is recommended to assess its sensitivity in the tracking of symptom changes after treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Pecs School of Medicine, Pecs, Hungary.
- National Laboratory on Human Reproduction, University of Pecs, Pecs, Hungary.
- Doctoral School of Health Sciences, Faculty of Health Sciences, University of Pecs, Pecs, Hungary.
- Institute of Bioanalysis, Medical School, University of Pecs, Pecs, Hungary.
- Institute of Behavioural Sciences, Medical School, University of Pecs, Pecs, Hungary. istvan.tiringer@aok.pte.hu.
- Member of the HUN-REN-PTE Human Reproduction Research Group, Hungarian Academy of Sciences (MTA), Pecs, Hungary.
ORCID-Profile: Istvan Tiringer
Förderung
- University of Pécs
Zitieren
APA
Kolumban, S., Farkas, N., Tiringer, I., Kovacs, K., Nemeth, Z., & Farkas, B. (2025). Hungarian Translation and Validation of the Pelvic Organ Prolapse Symptom Score. International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06090-5
Vancouver
Kolumban S, Farkas N, Tiringer I, Kovacs K, Nemeth Z, Farkas B. Hungarian Translation and Validation of the Pelvic Organ Prolapse Symptom Score. International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06090-5
BibTeX
@article{Kolumban2025,
author = {Kolumban, Szilard and Farkas, Nelli and Tiringer, Istvan and Kovacs, Kalman and Nemeth, Zoltan and Farkas, Balint},
title = {Hungarian Translation and Validation of the Pelvic Organ Prolapse Symptom Score},
journal = {International Urogynecology Journal},
year = {2025},
doi = {10.1007/s00192-025-06090-5}
}
EUVIMED